Medicine and Dentistry
Neoplasm
100%
Ovarian Cancer
86%
Cancer Cell
41%
Breast Cancer
36%
Malignant Neoplasm
25%
Stroma
24%
Fibroblast
19%
Immunity
18%
Metastatic Carcinoma
16%
Cancer Tissue
16%
Krukenberg Tumor
16%
Biopsy Technique
16%
Biological Marker
15%
Platelet
14%
Uterine Cancer
14%
Spectroscopic Imaging
14%
Tumor Microenvironment
13%
In Vitro
13%
Formestane
10%
Aromatase
10%
Trastuzumab
10%
Cell Death
9%
Serous Carcinoma
9%
Macrophage
9%
Primary Tumor
8%
Cancer
8%
DNA Damage
8%
Combination Therapy
8%
Liquid Biopsy
8%
Transcriptomics
8%
Antiangiogenic Therapy
8%
Vasculotropin
8%
Ovarian Tumor
8%
Targeted Therapy
8%
Solid Malignant Neoplasm
8%
CD8 Antigen
8%
Vasculotropin Antibody
7%
Estrogen Receptor
7%
Programmed Death-Ligand 1
7%
Prolactin Receptor
7%
Hazard Ratio
7%
Personalized Medicine
7%
Angiogenesis
7%
Clear Cell Renal Cell Carcinoma
7%
Progenitor Cell
7%
Colorectal Carcinoma
7%
DNA Synthesis
7%
Mesenchymal Stem Cell
7%
Ductal Carcinoma
7%
Mesothelin
7%
Keyphrases
High-grade Serous Ovarian Cancer (HGSOC)
52%
Tumor
42%
Ovarian Cancer
34%
Platelet-derived Growth Factor Receptor (PDGFR)
31%
Fibroblasts
23%
CD-8
15%
P130Cas
14%
Anti-angiogenesis
14%
Colorectal Cancer
14%
Perivascular Cells
14%
Antiangiogenesis Therapy
14%
CD11c
14%
Tumor Microenvironment
13%
Overall Survival
12%
High Density
9%
Tumor Stroma
9%
Metastasis
9%
T Cells
9%
Chemotherapy
8%
Macrophages
8%
Tumor Features
8%
DNA Damage
8%
Median Overall Survival
8%
Prognosis Marker
8%
Tumor Subtype
8%
Primary Tumor
8%
Poor Prognosis
8%
Tumor Tissue
7%
Poor Response
7%
Poor Outcome
7%
CD8+ Cells
7%
Multiparametric Assessment
7%
Spectroscopic Imaging
7%
Lung Carcinoma
7%
TP53 mutation
7%
Serous Ovarian Cancer
7%
Investigation Process
7%
Ductal Breast Carcinoma
7%
Blotting
7%
Subtype Classification
7%
Stroma Cells
7%
Author Affiliation
7%
Hazard Ratio
7%
Group Position
7%
Cell Optimization
7%
Renal Cell Carcinoma
7%
Astrocytes
7%
Tissue Biopsy
7%
Mammosphere
7%
DNA Replication
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
36%
Fibroblast
22%
Overall Survival
16%
Multivariate Analysis
15%
Angiogenesis
15%
Transcriptomics
14%
CD44
14%
CD8
12%
RNA Sequence
10%
Immunocompetent Cell
10%
Estrogen Receptor
9%
Formestane
9%
Genetics
9%
PD-L1
8%
RNA
8%
Quantitative Technique
8%
Vascularization
8%
Platelet
7%
Progenitor Cell
7%
Light Sheet Fluorescence Microscopy
7%
Cell Proliferation
7%
Cancer Staging
7%
Membrane Protein
7%
Transmembrane Protein
7%
Phenotypic Heterogeneity
7%
Mesothelin
7%
Infrared Radiation
7%
Metabolite
7%
Astrocyte
7%
Trastuzumab
7%
CD11c
7%
DNA Damage
7%
Mesenchymal-Epithelial Transition
7%
Epigenetics
7%
Glial Fibrillary Acidic Protein
7%
Mural Cell
7%
DNA Synthesis
7%
Cell Activity
7%
Microcirculation
7%
Genome Sequencing
7%
Platelet-Derived Growth Factor Receptor
7%
Metabolic Pathway
7%
Immune Microenvironment
7%
Tyrosine Kinase Inhibitor
7%
Oncogene
7%
P53
7%
Vascular Endothelial Growth Factor
7%
Antiangiogenic Activity
7%
Colon
7%
Aromatase
7%